Cyclopharm Limited (ASX:CYC)
Australia · Delayed Price · Currency is AUD 0.4700
+0.0100 (2.17%)
Oct 12, 2026, 4:10 PM AEST
Cyclopharm Market Cap
Cyclopharm has a market cap or net worth of 59.1 million as of October 12, 2026. It is the 31,959th most valuable company in the world and the 756th biggest in Australia. Its market cap has decreased by 20.64% in one year.
Market Cap
59.10M
Enterprise Value
54.65M
Revenue
34.42M
Global Rank
Country Rank
#756 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2007, Cyclopharm's market cap has increased from 50.89M to 59.10M, an increase of 16.12%. That is a compound annual growth rate of 0.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 59.10M | -45.74% |
| Dec 30, 2025 | 108.91M | -38.17% |
| Dec 31, 2024 | 176.15M | -2.75% |
| Dec 29, 2023 | 181.14M | 66.37% |
| Dec 30, 2022 | 108.87M | -28.90% |
| Dec 30, 2021 | 153.13M | -23.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saluda Medical | 102.07M |
| Lumos Diagnostics Holdings | 94.48M |
| Epiminder | 63.92M |
| SomnoMed | 60.44M |
| Compumedics | 48.94M |
| Micro-X | 48.16M |
| HeraMED | 45.19M |
| Cleo Diagnostics | 43.19M |